Zul Faizuddin Osman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zul Faizuddin Osman has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Azlina
Affiliation School of Dental Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia
2 shared publications - Farizan Ahmad
Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia
2 shared publications Jafri Malin Abdullah
Centre for Neuroscience Services and Research, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia
2 shared publications- Siti Nurnasihah Md Hashim
School of Dental Sciences, Health Campus, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
2 shared publications - Thirumulu Ponnuraj Kannan
Universiti Sains Malaysia
2 shared publications - Abdul Aziz Mohamed Yusoff
Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Kubang Kerian, Kelantan, Malaysia
1 shared publication
Latest Publications
- Open Access
- 30 April 2019
- Published by Penerbit Universiti Sains Malaysia in Malaysian Journal of Medical Sciences
- Vol. 26 (2) , 30-39
Anti-Cancer Properties of Heterotrigona itama sp. Honey Via Induction of Apoptosis in Malignant Glioma Cells
There has been increasing evidence showing that stingless bee honey exhibits anti-oxidant, anti-inflammatory and anti-cancer properties. Pharmacologically-active components in honey such as flavonoids and phenolic constituents are known to contribute to its medicinal benefits. To the best of our knowledge, this is the first study on evaluating anti-cancer effects of locally-produced Malaysian stingless bee honey from Heterotrigona itama sp. on malignant glioma cells. Proliferation and apoptosis studies of U-87 MG cells following stingless bee honey treatment were carried out using MTS assay and acridine orange/propidium iodide dual staining, respectively. Results demonstrated time and dose-dependent cytotoxicity using 0.625%, 1.25% and 10% stingless bee honey (P < 0.05). IC50 values were calculated using cells treated with 10% stingless bee honey. It was also observed that 10% stingless bee honey induced nuclear shrinkage, chromatin condensation and nucleus fragmentation, indicating that cellular changes were consistent with the apoptotic characteristics of the cells. These data provide a good basis for further evaluation of the medicinal properties of stingless bee honey from Heterotrigona itama sp. This source of honey may serve as a potential therapy for malignant glioma.
- 30 April 2019
- Published by Penerbit Universiti Sains Malaysia in Malaysian Journal of Medical Sciences
- Vol. 26 (2) , 30-39
Open AccessAnti-Cancer Properties of Heterotrigona itama sp. Honey Via Induction of Apoptosis in Malignant Glioma Cells
There has been increasing evidence showing that stingless bee honey exhibits anti-oxidant, anti-inflammatory and anti-cancer properties. Pharmacologically-active components in honey such as flavonoids and phenolic constituents are known to contribute to its medicinal benefits. To the best of our knowledge, this is the first study on evaluating anti-cancer effects of locally-produced Malaysian stingless bee honey from Heterotrigona itama sp. on malignant glioma cells. Proliferation and apoptosis studies of U-87 MG cells following stingless bee honey treatment were carried out using MTS assay and acridine orange/propidium iodide dual staining, respectively. Results demonstrated time and dose-dependent cytotoxicity using 0.625%, 1.25% and 10% stingless bee honey (P < 0.05). IC50 values were calculated using cells treated with 10% stingless bee honey. It was also observed that 10% stingless bee honey induced nuclear shrinkage, chromatin condensation and nucleus fragmentation, indicating that cellular changes were consistent with the apoptotic characteristics of the cells. These data provide a good basis for further evaluation of the medicinal properties of stingless bee honey from Heterotrigona itama sp. This source of honey may serve as a potential therapy for malignant glioma.
- Open Access
- 28 December 2018
- Published by Penerbit Universiti Sains Malaysia in Malaysian Journal of Medical Sciences
- Vol. 25 (6) , 22-27
Roles of EphA2 Receptor in Angiogenesis Signaling Pathway of Glioblastoma Multiforme
Glioblastoma multiforme (GBM) is one of the most common primary brain tumours in adults, accounting for almost 65% of all cases. Among solid tumours, GBM is characterised by strong angiogenesis, including the highest degree of vascular proliferation and endothelial cell hyperplasia. Despite numerous improvements in existing treatment approaches, the prognosis of GBM patients remains poor, with a mean survival of only 14.6 months. Growing evidence has shown significant overexpression of the ephrin type-A receptor 2 (EphA2) receptor in various malignancies, including GBM, as well as a correlation to poor prognoses. It is believed that EphA2 receptors play important roles in mediating GBM tumourigenesis, including invasion, metastasis, and angiogenesis. Despite the clinical and pathological importance of tumour-associated vasculature, the underlying mechanism involving EphA2 is poorly known. Here, we have summarised the current knowledge in the field regarding EphA2 receptors' roles in the angiogenesis of GBM.
- 28 December 2018
- Published by Penerbit Universiti Sains Malaysia in Malaysian Journal of Medical Sciences
- Vol. 25 (6) , 22-27
Open AccessRoles of EphA2 Receptor in Angiogenesis Signaling Pathway of Glioblastoma Multiforme
Glioblastoma multiforme (GBM) is one of the most common primary brain tumours in adults, accounting for almost 65% of all cases. Among solid tumours, GBM is characterised by strong angiogenesis, including the highest degree of vascular proliferation and endothelial cell hyperplasia. Despite numerous improvements in existing treatment approaches, the prognosis of GBM patients remains poor, with a mean survival of only 14.6 months. Growing evidence has shown significant overexpression of the ephrin type-A receptor 2 (EphA2) receptor in various malignancies, including GBM, as well as a correlation to poor prognoses. It is believed that EphA2 receptors play important roles in mediating GBM tumourigenesis, including invasion, metastasis, and angiogenesis. Despite the clinical and pathological importance of tumour-associated vasculature, the underlying mechanism involving EphA2 is poorly known. Here, we have summarised the current knowledge in the field regarding EphA2 receptors' roles in the angiogenesis of GBM.
- 1 January 2018
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 8 (1) , 48-53
Angiogenic and osteogenic potentials of dental stem cells in bone tissue engineering
- 1 January 2018
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 8 (1) , 48-53
Angiogenic and osteogenic potentials of dental stem cells in bone tissue engineering
- 15 February 2017
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 12 (3) , 197-206
Immunomodulatory Effect of Cytokines in the Differentiation of Mesenchymal Stem Cells: A Review
Mesenchymal stem cells (MSCs) are stromal origin cells with multilineage differentiation capacity. The immunoregulatory properties of MSCs can be interfered effectively by cytokines. Cytokines, produced by a broad range of cells, act at the systemic level to influence biological phenomena such as inflammation, wound healing, organogenesis and oncogenesis. Cytokines also play vital roles in the differentiation of MSCs into several cell lineages. This review summarizes on how cytokines can affect MSCs differentiation and their relative signaling pathways, which may serve to understand the possible underlying mechanisms. Also, this review reveals the potential clinical use of MSCs as promising therapeutic agents due to their special characteristics such as multipotent differentiation, immunomodulatory properties, and selfrestoration.
- 15 February 2017
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 12 (3) , 197-206
Immunomodulatory Effect of Cytokines in the Differentiation of Mesenchymal Stem Cells: A Review
Mesenchymal stem cells (MSCs) are stromal origin cells with multilineage differentiation capacity. The immunoregulatory properties of MSCs can be interfered effectively by cytokines. Cytokines, produced by a broad range of cells, act at the systemic level to influence biological phenomena such as inflammation, wound healing, organogenesis and oncogenesis. Cytokines also play vital roles in the differentiation of MSCs into several cell lineages. This review summarizes on how cytokines can affect MSCs differentiation and their relative signaling pathways, which may serve to understand the possible underlying mechanisms. Also, this review reveals the potential clinical use of MSCs as promising therapeutic agents due to their special characteristics such as multipotent differentiation, immunomodulatory properties, and selfrestoration.